Screener
BioMarin Pharmaceuticals BMRN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| ASSETS | June 30, 2026 / (unaudited) | December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Accounts receivable, net | 1,061,047 | 908,214 |
| Inventory | 1,782,524 | 1,298,883 |
| Other current assets | 254,047 | 185,784 |
| Total current assets | 3,971,623 | 3,953,490 |
| Noncurrent assets: | ||
| Long-term investments | — | 492,242 |
| Property, plant and equipment, net | 989,994 | 952,508 |
| Intangible assets, net | 4,879,367 | 213,837 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's total current assets?
- BioMarin Pharmaceuticals (BMRN) reported total current assets of $3.97B in Q2 2026.
- How has BioMarin Pharmaceuticals's total current assets changed year-over-year?
- BioMarin Pharmaceuticals's total current assets increased by 4.4% year-over-year, from $3.81B to $3.97B.
- What is the long-term trend for BioMarin Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total current assets has grown at a 11.0% compound annual growth rate (CAGR), from $2.34B to $3.95B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about BioMarin Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude